Enhancing access to HIV pre-exposure prophylaxis (PrEP) through a community-based project in New Zealand
Journal of Primary Health Care · 24.07.2026
DOI: 10.1071/hc26104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Primary Health Care, online erschienen am 24.07.2026. Verfasst von Charon Lessing und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Community and Public Health, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: New Zealand Pharmacy Education and Research Foundation.
Abstract (Originalsprache)
Introduction
New Zealand has maintained a low HIV prevalence through comprehensive screening, treatment, and prevention programmes. However, challenges remain with access to pre-exposure prophylaxis (PrEP) for at-risk populations, particularly men who have sex with men (MSM).
Aim
This study aimed to evaluate the implementation and outcomes of a community-based project that expanded PrEP access via a Standing Order authorising peer HIV testers and pharmacists to initiate short-term PrEP prior to general practitioner follow-up.
Methods
Conducted between May 2020 and July 2021, the project involved collaboration between a community-based HIV support organisation, a general medical practice, and a community pharmacy in Auckland. Participants received an initial 10-day PrEP supply following a negative HIV rapid test and screening for contraindications, with follow-up laboratory testing and prescriptions managed by the practitioner and pharmacist team.
Results
Thirty-six clients enrolled (aged 22–60 years). Most identified as European (n = 16), Asian (n = 10), or Māori (n = 8). No participants seroconverted to HIV during the study. Six sexually transmitted infections were diagnosed and treated. A degree of hepatocellular damage was reported in one participant, and mild but transient liver enzyme elevation occurred in a further five participants. No renal toxicity was recorded. The mean duration of PrEP use was approximately 12 months.
Discussion
This project demonstrated that community-initiated PrEP under a Standing Order can be a safe, acceptable, and effective method for expanding HIV prevention services amongst MSM. This model supports future policy directions to broaden PrEP access through trained pharmacists and community channels.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Community and Public Health, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand.
- Body Positive Inc. Victoria Street West, Auckland 1142, New Zealand.
- Independent researchers, Auckland, New Zealand.
ORCID-Profile: Charon Lessing
Förderung
- New Zealand Pharmacy Education and Research Foundation
Zitieren
APA
Lessing, C., Fisher, M., Hillebrand, H., & Hannon, R. (2026). Enhancing access to HIV pre-exposure prophylaxis (PrEP) through a community-based project in New Zealand. Journal of Primary Health Care. https://doi.org/10.1071/hc26104
Vancouver
Lessing C, Fisher M, Hillebrand H, Hannon R. Enhancing access to HIV pre-exposure prophylaxis (PrEP) through a community-based project in New Zealand. Journal of Primary Health Care. 2026. doi:10.1071/hc26104
BibTeX
@article{Lessing2026,
author = {Lessing, Charon and Fisher, Mark and Hillebrand, Harry and Hannon, Robbie},
title = {Enhancing access to HIV pre-exposure prophylaxis (PrEP) through a community-based project in New Zealand},
journal = {Journal of Primary Health Care},
year = {2026},
doi = {10.1071/hc26104}
}
EUVIMED